Natriuretic peptides regulate heart rate and sinoatrial node function by activating multiple natriuretic peptide receptors

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 5, 2012, Pages 715-724

  Azer, John ^a   Hua, Rui ^a   Vella, Kimberly ^a   Rose, Robert A ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Action potential; Electrocardiography; Natriuretic peptide receptors; Natriuretic peptides; Sinoatrial node

Indexed keywords

ATRIAL NATRIURETIC FACTOR ANTAGONIST; HORMONE RECEPTOR; ISOPRENALINE; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE RECEPTOR C; NATRIURETIC PEPTIDE TYPE B; NATRIURETIC PEPTIDE TYPE C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; HEART ATRIUM FUNCTION; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART RATE; HORMONE ACTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INDUCTION; RECEPTOR BLOCKING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SINUS NODE;

ADRENERGIC BETA-AGONISTS; ANIMALS; ATRIAL NATRIURETIC FACTOR; CELLS, CULTURED; HEART; HEART RATE; ISOPROTERENOL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDE, C-TYPE; PEPTIDE FRAGMENTS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SINOATRIAL NODE; TETRAHYDROISOQUINOLINES;

MUS;

EID: 84867403300     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.08.020     Document Type: Article

References (59)

1. Levin E.R., Gardner D.G., Samson W.K. Natriuretic peptides. N Engl J Med 1998, 339:321-328.
2. Potter L.R., Abbey-Hosch S., Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006, 27:47-72.
3. Rose R.A., Giles W.R. Natriuretic peptide C receptor signalling in the heart and vasculature. J Physiol 2008, 586:353-366.
4. Mangoni M.E., Nargeot J. Genesis and regulation of the heart automaticity. Physiol Rev 2008, 88:919-982.
5. Springer J., Azer J., Hua R., Robbins C., Adamczyk A., McBoyle S., et al. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors. J Mol Cell Cardiol 2012, 52:1122-1134.
6. Rose R.A., Lomax A.E., Kondo C.S., Anand-Srivastava M.B., Giles W.R. Effects of C-type natriuretic peptide on ionic currents in mouse sinoatrial node: a role for the NPR-C receptor. Am J Physiol Heart Circ Physiol 2004, 286:H1970-H1977.
7. Lucas K.A., Pitari G.M., Kazerounian S., Ruiz-Stewart I., Park J., Schulz S., et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 2000, 52:375-414.
8. Anand-Srivastava M.B., Trachte G.J. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 1993, 45:455-497.
9. Maack T., Suzuki M., Almeida F.A., Nussenzveig D., Scarborough R.M., McEnroe G.A., et al. Physiological role of silent receptors of atrial natriuretic factor. Science 1987, 238:675-678.
10. Potter L.R., Yoder A.R., Flora D.R., Antos L.K., Dickey D.M. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 2009, 341-366.
11. Anand-Srivastava M.B., Sehl P.D., Lowe D.G. Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. Involvement of a pertussis toxin-sensitive G protein. J Biol Chem 1996, 271:19324-19329.
12. Anand-Srivastava M.B. Natriuretic peptide receptor-C signaling and regulation. Peptides 2005, 26:1044-1059.
13. Pagano M., Anand-Srivastava M.B. Cytoplasmic domain of natriuretic peptide receptor C constitutes Gi activator sequences that inhibit adenylyl cyclase activity. J Biol Chem 2001, 276:22064-22070.
14. Zhou H., Murthy K.S. Identification of the G protein-activating sequence of the single-transmembrane natriuretic peptide receptor C (NPR-C). Am J Physiol Cell Physiol 2003, 284:C1255-C1261.
15. Rose R.A., Lomax A.E., Giles W.R. Inhibition of L-type Ca2+ current by C-type natriuretic peptide in bullfrog atrial myocytes: an NPR-C-mediated effect. Am J Physiol Heart Circ Physiol 2003, 285:H2454-H2462.
16. Lee C.Y., Burnett J.C. Natriuretic peptides and therapeutic applications. Heart Fail Rev 2007, 12:131-142.
17. Rose R.A. CD-NP, a chimeric natriuretic peptide for the treatment of heart failure. Curr Opin Investig Drugs 2010, 11:349-356.
18. Boerrigter G., Lapp H., Burnett J.C. Modulation of cGMP in heart failure: a new therapeutic paradigm. Handb Exp Pharmacol 2009, 485-506.
19. Azer J., Robbins C., Springer J., Adamczyk A., Hua R., Rose R.A. B-type and C-type natriuretic peptides regulate heart rate and sinoatrial node function by activating multiple natriuretic peptide receptor subtypes. Circulation 2012, 124:A15759. [Suppl., Ref Type: Abstract].
20. Jaubert J., Jaubert F., Martin N., Washburn L.L., Lee B.K., Eicher E.M., et al. Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). Proc Natl Acad Sci U S A 1999, 96:10278-10283.
21. Cifelli C., Rose R.A., Zhang H., Voigtlaender-Bolz J., Bolz S.S., Backx P.H., et al. RGS4 regulates parasympathetic signaling and heart rate control in the sinoatrial node. Circ Res 2008, 103:527-535.
22. Rose R.A., Sellan M., Simpson J.A., Izaddoustdar F., Cifelli C., Panama B.K., et al. Iron overload decreases CaV1.3-dependent L-type Ca2+ currents leading to bradycardia, altered electrical conduction, and atrial fibrillation. Circ Arrhythm Electrophysiol 2011, 4:733-742.
23. Anand-Srivastava M.B., Sairam M.R., Cantin M. Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system. J Biol Chem 1990, 265:8566-8572.
24. Delporte C., Winand J., Poloczek P., Von Geldern T., Christophe J. Discovery of a potent atrial natriuretic peptide antagonist for ANPA receptors in the human neuroblastoma NB-OK-1 cell line. Eur J Pharmacol 1992, 224:183-188.
25. Trachte G.J. Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens. J Pharmacol Exp Ther 1993, 264:1227-1233.
26. DiFrancesco D. Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol 1993, 55:455-472.
27. Irisawa H., Brown H.F., Giles W. Cardiac pacemaking in the sinoatrial node. Physiol Rev 1993, 73:197-227.
28. Lakatta E.G., Maltsev V.A., Vinogradova T.M. A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker. Circ Res 2010, 106:659-673.
29. Mangoni M.E., Couette B., Bourinet E., Platzer J., Reimer D., Striessnig J., et al. Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci U S A 2003, 100:5543-5548.
30. Zhang Z., Xu Y., Song H., Rodriguez J., Tuteja D., Namkung Y., et al. Functional roles of Ca(v)1.3 (alpha(1D)) calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice. Circ Res 2002, 90:981-987.
31. Zaccolo M., Movsesian M.A. cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology. Circ Res 2007, 100:1569-1578.
32. Clark R.B., Mangoni M.E., Lueger A., Couette B., Nargeot J., Giles W.R. A rapidly activating delayed rectifier K+ current regulates pacemaker activity in adult mouse sinoatrial node cells. Am J Physiol Heart Circ Physiol 2004, 286:H1757-H1766.
33. Heath B.M., Terrar D.A. Protein kinase C enhances the rapidly activating delayed rectifier potassium current, IKr, through a reduction in C-type inactivation in guinea-pig ventricular myocytes. J Physiol 2000, 522(Pt 3):391-402.
34. Lei M., Jones S.A., Liu J., Lancaster M.K., Fung S.S., Dobrzynski H., et al. Requirement of neuronal- and cardiac-type sodium channels for murine sinoatrial node pacemaking. J Physiol 2004, 559:835-848.
35. Lei M., Zhang H., Grace A.A., Huang C.L. SCN5A and sinoatrial node pacemaker function. Cardiovasc Res 2007, 74:356-365.
36. Maier S.K., Westenbroek R.E., Yamanushi T.T., Dobrzynski H., Boyett M.R., Catterall W.A., et al. An unexpected requirement for brain-type sodium channels for control of heart rate in the mouse sinoatrial node. Proc Natl Acad Sci U S A 2003, 100:3507-3512.
37. Baruscotti M., DiFrancesco D., Robinson R.B. Na(+) current contribution to the diastolic depolarization in newborn rabbit SA node cells. Am J Physiol Heart Circ Physiol 2000, 279:H2303-H2309.
38. Baruscotti M., Westenbroek R., Catterall W.A., DiFrancesco D., Robinson R.B. The newborn rabbit sino-atrial node expresses a neuronal type I-like Na+ channel. J Physiol 1997, 498(Pt 3):641-648.
39. Cantrell A.R., Tibbs V.C., Yu F.H., Murphy B.J., Sharp E.M., Qu Y., et al. Molecular mechanism of convergent regulation of brain Na(+) channels by protein kinase C and protein kinase A anchored to AKAP-15. Mol Cell Neurosci 2002, 21:63-80.
40. Chen Y., Yu F.H., Surmeier D.J., Scheuer T., Catterall W.A. Neuromodulation of Na+ channel slow inactivation via cAMP-dependent protein kinase and protein kinase C. Neuron 2006, 49:409-420.
41. Matsuda J.J., Lee H., Shibata E.F. Enhancement of rabbit cardiac sodium channels by beta-adrenergic stimulation. Circ Res 1992, 70:199-207.
42. Murphy B.J., Rogers J., Perdichizzi A.P., Colvin A.A., Catterall W.A. cAMP-dependent phosphorylation of two sites in the alpha subunit of the cardiac sodium channel. J Biol Chem 1996, 271:28837-28843.
43. Rose R.A., Hatano N., Ohya S., Imaizumi Y., Giles W.R. C-type natriuretic peptide activates a non-selective cation current in acutely isolated rat cardiac fibroblasts via natriuretic peptide C receptor-mediated signalling. J Physiol 2007, 580:255-274.
44. Camelliti P., Green C.R., LeGrice I., Kohl P. Fibroblast network in rabbit sinoatrial node: structural and functional identification of homogeneous and heterogeneous cell coupling. Circ Res 2004, 94:828-835.
45. Chilton L., Giles W.R., Smith G.L. Evidence of intercellular coupling between co-cultured adult rabbit ventricular myocytes and myofibroblasts. J Physiol 2007, 583:225-236.
46. Kohl P., Camelliti P., Burton F.L., Smith G.L. Electrical coupling of fibroblasts and myocytes: relevance for cardiac propagation. J Electrocardiol 2005, 38(Suppl.):45-50.
47. Ju Y.K., Chu Y., Chaulet H., Lai D., Gervasio O.L., Graham R.M., et al. Store-operated Ca2+ influx and expression of TRPC genes in mouse sinoatrial node. Circ Res 2007, 100:1605-1614.
48. Reichelt M.E., Willems L., Hack B.A., Peart J.N., Headrick J.P. Cardiac and coronary function in the Langendorff-perfused mouse heart model. Exp Physiol 2009, 94:54-70.
49. Chan N.Y., Seyedi N., Takano K., Levi R. An unsuspected property of natriuretic peptides: promotion of calcium-dependent catecholamine release via protein kinase G-mediated phosphodiesterase type 3 inhibition. Circulation 2012, 125:298-307.
50. Herring N., Zaman J.A., Paterson D.J. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway. Am J Physiol Heart Circ Physiol 2001, 281:H2318-H2327.
51. Barr C.S., Rhodes P., Struthers A.D. C-type natriuretic peptide. Peptides 1996, 17:1243-1251.
52. Del Ry S., Passino C., Emdin M., Giannessi D. C-type natriuretic peptide and heart failure. Pharmacol Res 2006, 54:326-333.
53. Ellmers L.J., Knowles J.W., Kim H.S., Smithies O., Maeda N., Cameron V.A. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis. Am J Physiol Heart Circ Physiol 2002, 283:H707-H714.
54. Kuhn M. Molecular physiology of natriuretic peptide signalling. Basic Res Cardiol 2004, 99:76-82.
55. Daniels L.B., Maisel A.S. Natriuretic peptides. J Am Coll Cardiol 2007, 50:2357-2368.
56. Pfisterer M., Buser P., Rickli H., Gutmann M., Erne P., Rickenbacher P., et al. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients with Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 2009, 301:383-392.
57. Wei C.M., Heublein D.M., Perrella M.A., Lerman A., Rodeheffer R.J., McGregor C.G., et al. Natriuretic peptide system in human heart failure. Circulation 1993, 88:1004-1009.
58. Beaulieu P., Cardinal R., Page P., Francoeur F., Tremblay J., Lambert C. Positive chronotropic and inotropic effects of C-type natriuretic peptide in dogs. Am J Physiol 1997, 273:H1933-H1940.
59. Lee C.Y., Chen H.H., Lisy O., Swan S., Cannon C., Lieu H.D., et al. Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects. J Clin Pharmacol 2009, 49:668-673.